These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 799307)
21. Risks associated with fresh whole blood and red blood cell transfusions in a combat support hospital. Spinella PC; Perkins JG; Grathwohl KW; Repine T; Beekley AC; Sebesta J; Jenkins D; Azarow K; Holcomb JB; Crit Care Med; 2007 Nov; 35(11):2576-81. PubMed ID: 17828033 [TBL] [Abstract][Full Text] [Related]
22. Detection of HBV genome by gene amplification method in HBsAg negative blood donors. Bodhiphala P; Chaturachumroenchai S; Chiewsilp P; Pruksananonda P J Med Assoc Thai; 1999 May; 82(5):491-5. PubMed ID: 10443099 [TBL] [Abstract][Full Text] [Related]
23. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa. Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474 [TBL] [Abstract][Full Text] [Related]
24. Markers for transfusion-associated hepatitis in north Indian blood donors: prevalence and trends. Singh B; Verma M; Verma K Jpn J Infect Dis; 2004 Apr; 57(2):49-51. PubMed ID: 15118208 [TBL] [Abstract][Full Text] [Related]
25. 'How frequent is posttranfusion hepatitis after the introduction of 3rd generation donor screening for hepatitis B? What is its probable nature? Vox Sang; 1977; 32(6):346-63. PubMed ID: 898833 [TBL] [Abstract][Full Text] [Related]
26. Characterization of HBV DNA+/HBsAg- blood donors in Poland identified by triplex NAT. Brojer E; Grabarczyk P; Liszewski G; Mikulska M; Allain JP; Letowska M; Hepatology; 2006 Dec; 44(6):1666-74. PubMed ID: 17133474 [TBL] [Abstract][Full Text] [Related]
28. Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test. Kleinman SH; Strong DM; Tegtmeier GG; Holland PV; Gorlin JB; Cousins C; Chiacchierini RP; Pietrelli LA Transfusion; 2005 Aug; 45(8):1247-57. PubMed ID: 16078909 [TBL] [Abstract][Full Text] [Related]
29. Hepatitis B virus infection in allogeneic bone marrow transplantation. Ustün C; Koç H; Karayalcin S; Akyol G; Gürman G; Ilhan O; Akan H; Ozcan M; Arslan O; Konuk N; Uysal A; Beksaç M Bone Marrow Transplant; 1997 Aug; 20(4):289-96. PubMed ID: 9285543 [TBL] [Abstract][Full Text] [Related]
30. Efficacy of serologic marker screening in identifying hepatitis B virus infection in organ, tissue, and cell donors. Challine D; Chevaliez S; Pawlotsky JM Gastroenterology; 2008 Oct; 135(4):1185-91. PubMed ID: 18694749 [TBL] [Abstract][Full Text] [Related]
31. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors? Busch MP Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546 [TBL] [Abstract][Full Text] [Related]
32. Acute hepatitis B virus window-period blood donations detected by individual-donation nucleic acid testing: a report on the first two cases found and interdicted in Spain. González R; Echevarria JM; Avellón A; Barea L; Castro E Transfusion; 2006 Jul; 46(7):1138-42. PubMed ID: 16836560 [TBL] [Abstract][Full Text] [Related]
33. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey. Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR; Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163 [TBL] [Abstract][Full Text] [Related]
34. Hepatitis after the transfusion of frozen red cells and washed red cells. Haugen RK N Engl J Med; 1979 Aug; 301(8):393-5. PubMed ID: 460339 [TBL] [Abstract][Full Text] [Related]
35. [Comparative studies of the distribution of hepatitis B markers among blood donors and patients with post-transfusion hepatitis in the city of Sofia]. Gubev E; Rashkov R; Dimitrova T; Sharankov N; Andonov A Vutr Boles; 1987; 26(3):38-43. PubMed ID: 3617705 [TBL] [Abstract][Full Text] [Related]
36. Prevalence of hepatitis B in a high-risk setting: a serologic study of patients and staff in a pediatric oncology unit. Tabor E; Gerety RJ; Mott M; Wilbur J Pediatrics; 1978 May; 61(5):711-5. PubMed ID: 662509 [TBL] [Abstract][Full Text] [Related]
37. Type B and non-B viral hepatitis in Jerusalem. Sandler SG; Shouval D; Marcus M; Eliakim M Bull World Health Organ; 1976; 54(2):193-8. PubMed ID: 1088102 [TBL] [Abstract][Full Text] [Related]
38. Etiological spectrum of post-transfusion hepatitis. Knodell RG; Conrad ME; Dienstag JL; Bell CJ Gastroenterology; 1975 Dec; 69(6):1278-85. PubMed ID: 172400 [TBL] [Abstract][Full Text] [Related]
39. Hepatitis B and residual risk of infection in English and Welsh blood donors, 1996 through 2008. Brant LJ; Reynolds C; Byrne L; Davison KL Transfusion; 2011 Jul; 51(7):1493-502. PubMed ID: 21470235 [TBL] [Abstract][Full Text] [Related]